跳至主要内容
临床试验/IRCT20150310021420N4
IRCT20150310021420N4招募中未知

Evaluation of the effect of letrozole addition to GnRH-antagonist protocol on IVF/ICSI cycle outcome in women with endometriosis

Tehran University of Medical Sciences0 个研究点目标入组 144 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 42 years(—)
性别
Female

入选标准

  • consent to participation
  • aged between 18 to 42 years
  • BMI ranged between 18.5 to 24.9
  • endometriosis-induced infertility and ICSI-IVF candidate
  • Endometriosis diagnosed by pathology reports

排除标准

  • Sever Male Factor
  • Evidence of reduced ovarian reserve (FSH levels above 10, AMH levels lower than 1, AFC reduction)
  • Endocrine disorders (diabetes - Thyroid diseases - Hyperprolactinemia - Hypothalamic amenorrhea and ...)
  • Known case of medical and immunologic diseases (lupus, rheumatoid arthritis, antiphospholipid syndrome, cardiovascular, liver and kidney disease)
  • Congenital anomalies of the uterus and endometrial cavity problems (bicorn or Unicorn uterus, Asherman syndrome, myoma, polyps, etc.)
  • Candidate for donation (egg donation and surrogacy)
  • Recurrent IVF failures (more than three consecutive failures)

研究者

相似试验